(R)-Elagolix NEW
| Price | $48 | $73 | $147 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-17 |
Product Details
| Product Name: (R)-Elagolix | CAS No.: 834153-87-6 |
| Purity: 99.08% | Supply Ability: 10g |
| Release date: 2026/07/17 |
Product Introduction
Bioactivity
| Name | (R)-Elagolix |
| Description | (R)-Elagolix (NBI-56418) is a short-acting, nonpeptide, GnRH antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively. administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose-dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full suppression at higher doses. |
| Storage | Store at low temperature Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 125 mg/mL (197.91 mM), Sonication is recommended. 10% DMSO+90% Saline : < 10 mg/mL (15.83 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (15.83 mM), Solution. |
| Keywords | NBI56418 | NBI 56418 | Inhibitor | inhibit | Gonadotropin releasing hormone receptor | GNRHReceptor | GNRHR | GnRH Receptor | Elagolix | (R)-Elagolix | (R)Elagolix | (R) Elagolix |
| Inhibitors Related | BAY-784 | Fluorogestone acetate | Degarelix acetate(214766-78-6 free base) | Relugolix | BAY 1214784 | Opigolix | Goserelin acetate | Linzagolix choline | Alarelin Acetate | Linzagolix | Cetrorelix diacetate | AG 045572 |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Fluorochemical Library | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $48.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-17 | |
|
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | |||
|
Shaanxi Haibo Biotechnology Co., Ltd
|
2024-04-12 | |||
| $300.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2023-06-26 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-02-26 | ||
| $2000.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY